Project: Early response prediction and resistance evaluation to hormonal treatment in patients suffering from metastasised breast carcinoma by means of radiolabelled somatostatin and epidermal growth factor.
- project duration
- 01-JAN-02 – 31-DEC-05
- The currently available tools for therapy respons prediction to hormonal treatment of metastasised breast carcinoma patients are inadequate and result in an unnecessarily delay of more benicial treatment in roughly 50% of patients. Scintigraphic evaluation of EGF and down regulation of S52R should allow reduction of this figure.